Medtech offers booster shot for Singapore's biomed

IT'S been a tough year for the manufacturing sector, but the medical technology sub-sector has had a standout performance so far and is expected to continue to do well on the back of growing...

Singapore healthtech startups attract US$105m in 2018

HEALTHTECH startups in Singapore attracted US$105 million across 21 deals in 2018, according to a report published by healthtech researcher Galen Growth Asia in collaboration with Singapore's...

Medtech hub opens with support from healthcare clusters

A NEW hub connecting startups, organisations and professionals in the healthcare industry opened its doors to the community on Monday.

Dialysis device startup Advent Access soothes kidney patients' pain

KIDNEY-failure patients undergoing hemodialysis suffer numerous needle insertions every week, with each prick running the risk of pain, ineffectiveness and wearing out the target vein.

Paving its way to deliver quality healthcare

IN the past year since Clearbridge Health was listed on the Singapore Exchange's Catalist board in Dec 2017, the healthcare group has been busy.

Medtech firm Ark launched with US$40m Series A funding

IN A BOLD move for venture capital firms in the region, Singapore's Venturecraft has merged with medtech startup Mirxes to form Ark Bio, a cancer detection company armed with a US$40 million...

CapitaLand joint venture buys Collective Works' co-working business

SINGAPORE - A joint venture between CapitaLand and The Work Project, known as The Work Project Kingdom (TWPK), has acquired Collective Works' co-working business for an undisclosed amount.

Advent Access secures global manufacturing, commercialisation rights to Vwing vascular needle guide

SINGAPORE - Homegrown medtech startup Advent Access has acquired the global manufacturing and commercialisation rights to the Vwing Vascular Needle Guide product line and other key assets from US...

Trendlines seeks investors' patience amid weak share price

CATALIST-listed startup incubator Trendlines on Wednesday urged investors to have patience and trust that the market will catch on to the company's business model - even as Trendlines stock, which...

Trendlines reveals its 'Most Valuable Portfolio company' to be Stimatix, valued at US$42.6m

TRENDLINES - the Catalist-listed, Israel and Singapore-based incubator of medtech and agritech startups - has finally disclosed Stimatix GI, its colostomy-device portfolio company, as its "Most...

Trendlines invests in Singapore medtech

THE Trendlines Group has had a good start to 2018.